Nose and Throat (ENT) News and Research

RSS

Anosmia (loss of smell) confirmed as a clinical feature of COVID-19

Earlier last month, the association of ear, nose, and throat (ENT) specialists in the UK issued a public statement advising patients with a sudden loss of smell or taste to get tested for COVID-19. They cited not only their own observations but those from numerous other ENT consultants the world around. A review of multiple papers on the sinus and nasal symptoms and signs related to the diagnosis of COVID-19, published in April 2020, in the journal Laryngoscope Investigative Otolaryngology, reiterates this finding.

15 Apr 2020

COVID19 patients describe a loss of smell and taste

Some medical specialists think that the sudden inability to smell or taste familiar odors and flavors could be an early sign of the novel coronavirus infection. This sign could be as innocuous-looking as feeling that food suddenly tastes bland, or that familiar strong smells aren't getting through. Yet, it could signal the need to isolate oneself because it is a little-known yet characteristic sign of COVID-19, the disease caused by the novel coronavirus that is racing around the world.

23 Mar 2020

Lyra Therapeutics announces presentation of Phase 1 clinical data for LYR-210 in CRS patients

Lyra Therapeutics, Inc., a clinical-stage biotechnology company developing medicines precisely designed to target ear, nose and throat diseases, today announced the presentation of Phase 1 clinical data for the company's lead therapeutic, LYR-210, for chronic rhinosinusitis, a debilitating disease caused by inflammation of the paranasal sinus tissues that affects approximately 27 million people, or 11% of the adult population in the U.S.

8 Oct 2018

FDA provides guidance on Novus Therapeutics’ development path for OP-02 to treat otitis media

Novus Therapeutics, Inc., a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat, announced receipt of final meeting minutes from the U.S. Food and Drug Administration following a Type C meeting held at the Company's request to discuss its OP-02 development program in otitis media.

19 Jun 2018

Eating honey can reduce serious injuries in children who swallowed button battery, shows study

A team of ear, nose, and throat specialists has demonstrated that eating honey after swallowing a button battery has the potential to reduce serious injuries in small children.

11 Jun 2018

NUS scientists develop novel handheld device for treatment of 'glue ear' in children

A team of researchers from the National University of Singapore has developed a novel handheld device, known as CLiKX, for the treatment of a condition called Otitis Media with Effusion, or 'glue ear', which is the leading cause of hearing loss and visits to the doctors among children worldwide.

24 May 2017

More than 1,000 patients at Sheffield Teaching Hospitals benefit from high-tech robot

More than 1,000 patients at Sheffield Teaching Hospitals have now benefitted from a high-tech robot that enables surgeons to perform highly precise and minimally-invasive surgery.

1 Feb 2017

ALPHAEON agrees to bring Zelegent's office-based Elevoplasty technology to sleep specialists

ALPHAEON Corporation, a subsidiary of Strathspey Crown Holdings LLC, and Zelegent, Inc. jointly announced today that the two companies have entered into an exclusive worldwide agreement to bring Zelegent's office-based Elevoplasty technology to board certified sleep specialists.

15 Dec 2015

Boston Scientific, Brainlab form strategic collaboration

Boston Scientific Corporation announces a collaboration with Brainlab AG, a leading software-driven medical technology company that helps improve patient treatment planning and surgical navigation.

28 Apr 2015

Spirox closes $18.5 million Series B round of financing

Spirox Inc., a privately held medical device company, announced today the closing of an $18.5 million Series B round of financing led by Venrock and Aisling Capital. Existing investors Aperture Venture Partners, Correlation Ventures and Western Technology Investment also participated in the round.

20 Apr 2015

Loyola otolaryngologist offers tips to identify, treat ear infection in children

Earaches in babies are not uncommon. But a baby's inability to communicate symptoms can leave most parents feeling helpless. According to the American Academy of Pediatrics, three-fourths of babies will get at least one ear infection before the age of one.

8 Apr 2015

Fiagon's ENT Extended Instrument Set receives FDA approval

Fiagon AG medical technologies announced today that it received U.S. Food and Drug Administration 510(k) clearance for its ear, nose and throat (ENT) Extended Instrument Set. The clearance includes the company's tip-navigated GuideWire, PointerShell instrument adaptor and FlexTube navigated suction and irrigation.

4 Dec 2014

Ethnicity may play role in occurrence of surgery-related breathing problems in children

Ethnicity may play a role in the occurrence of breathing problems during and after surgery, suggests preliminary results from a new study presented at the ANESTHESIOLOGY 2014 annual meeting.

15 Oct 2014

Acclarent releases ACCLARENT AERA Eustachian Tube Balloon Dilation System for ETD treatment

Acclarent, Inc. announced today the launch of the ACCLARENT AERA Eustachian Tube Balloon Dilation System for the treatment of adult patients with Eustachian Tube Dysfunction (ETD), a condition marked by ear pain, pressure and dulled hearing.

18 Sep 2014

Saint-Gobain Seals continues its long-standing relationship with OEMs

Saint-Gobain Seals continues its long-standing relationship with OEMs in the high-speed surgical drill market as their integral supplier of OmniSeal® spring-energized seals. The seals excel at protecting the sensitive internal components of the drill during surgery and sterilization, ensuring a long life of the tool.

17 Jun 2014

Acclarent announces availability of Relieva Spin Balloon Sinuplasty System for sinusitis treatment

Acclarent, Inc. announced today the U.S. availability of the Relieva Spin Balloon Sinuplasty System with the M-110C Sinus Guide Catheter Tip designed to access small and tight sinus anatomy in children and adults. This innovation represents a new addition to Acclarent's Balloon Sinuplasty portfolio, which physicians use to treat children who suffer from chronic maxillary sinusitis.

23 Jan 2014

Reflux disease diagnosis: an interview with Professor Peter Dettmar, Managing Director of RD Biomed Limited

Generally speaking, reflux has been a major chronic issue for probably the last 40 or 50 years. When you look at the global population, depending on which country we're talking about, around 20% to 40% of individuals have reflux disease within their populations.

23 Dec 2013

Mass. Eye and Ear's OGSH launches new collaboration to care for people ENT diseases

Rates of death and disability stemming from ear, nose and throat conditions continue to rise in developing countries like Uganda, but despite the need, fewer than 15 operating ear, nose and throat surgeons serve Uganda's 33.4 million and growing population. Only two ENT residency programs exist in this country, but many trainees do not remain in the country after graduation. Mass. Eye and Ear's Office of Global Surgery and Health is launching a new collaboration with Mbarara University Science and Technology School of Medicine and Mbarara Regional Referral Hospital to help address the need for more trained physicians to care for the ENT diseases and conditions of this population and to help encourage those who are ENT trained to stay in the country to care for those who need them.

16 Nov 2013

Pergamum’s DPK-060 Phase II trial on acute external otitis meets primary end-point

Pergamum AB announced today that the primary end-point was met in the randomized Phase II trial of DPK-060 for treatment of acute external otitis.

21 Dec 2012

Bacterial pathogen ‘acutely’ involved in otitis media

Alloiococcus otitidis can be a dominant bacterial pathogen among indigenous Australian children with acute otitis media with perforation, although its main role appears to be that of a secondary pathogen, preliminary study findings suggest.

10 Oct 2012